ARCHIVES

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Pitt Inquiry Panel Proceedings Suspended, ORI To Take Over NSABP Investigation

July 22, 1994

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

December 2, 1994

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994

Natural Product Drug Discovery Groups Receive Concept Approval

February 26, 1988

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000